cagrilintide tirzepatide blend is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination Cagrilintide is a long-acting amylin

For those interested in deeper genetic insights, the Precision Peptide Genetic Test ($99 add-on after your first month) examines 14 pathways and 150+ genetic insights, including variants in the GLP1R gene that influence your individual response to tirzepatide therapy

Limitations: Limitations of this study include a limited amount of literature regarding the relationship between GLP-1 agonists and acne vulgaris

2023;102: e34671

But until there's more data there, as far as looking at large populations and cancer incidence, like breast cancer, there is no increased incidence of breast cancer in patients taking GLP-1, and in fact, there seems to be a reduction in obesity-related cancers in those groups taking GLP-1

And can true change happen without systemic overhaul